-
-
-
Sequence
- GLSKGCFGLKLDRIGSMSGLGCPSLRDPRPDAPSTSA
-
Description
- Synthetic chimeric 37-mer derived from combination of two natriuretic peptides
-
-
Target Organism
-
- No MICs found on DRAMP database
-
Reference
-
- A PHASE II, DOSE-RANGING STUDY WITHÂ CD-NP, A CHIMERIC NATRIURETIC PEPTIDE, IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS WITH RENAL COMPROMISE
-
Medical use
- Acute decompensated failure (ADHF),Organ failure
-
Company
- Nile Therapeutics (United States, Minnesota).
-
Stage of Development
- Phase II
-
- CD-NP at 1.25 and 2.5 ng/kg/min appeared to preserve renal function relative to placebo as measured by renal biomarkers
-
Clinical Trials
- NCT02071602
- NCT02359227
- NCT02603614
- NCT00839007
- NCT00699712